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INTRODUCTION
Malignant soft tissue tumors rarely occur in the
head and neck, and surgeons find it difficult to deter-
mine the optimal method for excising these tumors,
particularly those located in the face. Malignant soft
tissue tumors are generally resected along with
thick surgical barriers, such as ligaments or the pe-
riosteum. However, resection involving such barriers
is difficult, due to the serious risks posed when the
tumor to be resected is situated adjacent to impor-
tant organs in the face. Moreover, accurate diagnosis
of soft tissue tumors is often complicated even for
well-trained pathologists due to the histologic char-
acteristics of these tumors. Low-grade fibromyxoid
sarcoma (LGFMS) is a rare type of sarcoma ; deter-
mination of the disease course based on oncologic
and histologic features remains controversial (1-3).
Moreover, the efficacy and advantages of adjuvant
therapy for this neoplasm have not been elucidated.
We describe here the case of an elderly woman with
recurring facial LGFMS that occurred at a rare lo-
cation and an unusual age.
CASE REPORT
An 84-year-old woman noticed a subcutaneous,
gradually enlarging tumor on her face. The tumor
was firm and immobile, approximately 32 cm in
size, and located on the right forehead (Fig. 1).
Magnetic resonance imaging (MRI) revealed that
the mass was connected to the deep temporal fas-
cia, appearing as a low-intensity area on T1 images
and a high-intensity area on T2 images (Fig. 2 a, b).
No metastasis was noted on computed tomography.
Based on MRI findings, the mass was found to re-
semble nodular fasciitis or a tumor such as a heman-
gioma or fibroma. We performed an excisional bi-
opsy to confirm the diagnosis. Histologic examina-
tion of the biopsy specimen revealed fibrous and
myxoid components (Fig. 3 a, b). The fibrous parts
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comprised spindle-shaped cells in a linear arrange-
ment showing whorled and swirling growth patterns,
whereas the myxoid parts comprised spindle to
stellate-shaped cells with an abundant intercellular
matrix and, in some parts, relatively rich vascular
networks. The tumor cells contained oval or short
spindle-shaped nuclei without a high degree of atyp-
ism or pleomorphism. Immunohistochemical exami-
nation revealed diffuse positivity to anti-vimentin
antibody, whereas tests for other antibodies were
negative (Table 1). Based on the histologic findings,
including the absence of nuclear atypism or pleo-
morphism, and the presence of predominant fibrous
components, we diagnosed the tumor as LGFMS,
not myxofibrosarcoma. Although we recommended
an additional wide excision, the patient refused. One
year later, the tumor recurred at the same location.
We had previously resected the recurrent tumor
with a 1-cm skin margin, including the temporal
branch of the facial nerve and the temporal muscle,
and reconstructed the defect with the remaining
Figure 1 : Photograph showing subcutaneous tumor on the right
forehead. It was approximately 32 cm in size.
Figure 2 : (a) MRI revealed the mass (arrows) in the subcuta-
neous tissue, appearing as a low-intensity area on T1 images.
(b) The mass (arrows) was showed as a high-intensity area on
T2 images.
Figure 3 : (a) The tumor composed of fibrous (small arrow) and
myxoid (large arrow) components. (heamatoxylin and eosin stain,
100) (b) The spindle-shaped cells (small arrow) were found
in the fibrous parts, the spindle to stellate -shaped cells (large
arrow) with an abundant intercellular matrix in the myxoid parts.
(heamatoxylin and eosin stain,400)
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temporal muscle flap and a skin graft (Fig. 4). At
that time, we also completely dissected the tumor
postoperatively under a microscope. Despite this
approach, the tumor recurred 2 cm away from the
skin graft 15 months after the first surgery. We per-
formed additional surgical excision with a 2-cm skin
margin, including the periosteum, and covered the
defect with a local skin flap (Fig. 5). At present, 1
year after the second excision, there is no evidence
of recurrence or metastasis of the LGFMS.
DISCUSSION
LGFMS is a rare tumor type first described by
Evans in 1987 (1). In the original description,
LGFMS was histologically characterized as a bland-
appearing soft tissue neoplasm, but the tumor was
found to be associated with aggressive behavior and
a high degree of local recurrence or distant metas-
tasis. In the second paper, Evans reported that 9 of
the 12 patients examined experienced local recur-
rence and that 7 who experienced distant metasta-
sis died from LGFMS (2). However, Folpe et al. de-
scribed that, of their 54 patients, local recurrence
and distant metastasis were seen in 5 (9%) and 3
(3%) patients, respectively (3). In addition, the diag-
nosis of LGFMS or “sarcoma” was made at the in-
itial presentation in 51 of these cases ; therefore,
wide and adequate surgical excision could be per-
formed. The authors also highlighted that early
surgery was one of the reasons why the rates of lo-
cal recurrence and distant metastasis in their series
were much lower than those of previous reports.
The most frequently reported location of LGFMS is
the lower extremity, especially the thigh, followed
by the trunk and groin, upper extremity, and but-
tock. The head and neck region is a very rare loca-
tion for this sarcoma, as based on previous reports
(1-5).
Histologically, LGFMS shows alternating fibrous
and myxoid areas and a swirling and whorled growth
pattern. The fibrous area contains deceptively be-
nign-appearing fibroblastic cells, with low to mod-
erate cellularity, uncommon mitotic figures, and ab-
sent or slight nuclear pleomorphism. The myxoid
area comprises spindle to stellate-shaped cells with
an abundant intercellular matrix. Furthermore, Evans
described that some recurrent and metastatic tumors
contain zones of increased cellularity and mitotic ac-
tivity. In our case, we observed high cellularity in
only some areas. However, further follow-up is nec-
essary to determine whether the presence of these
areas impairs the recurrence and metastatic rate of
LGFMS. Immunohistochemically, most cells of this
Table 1. The results for immunohistochemical staining
Positive Negative
Vimentin Desmin, α -SMA, CD-34, CD-56, S-100 protein, cytokeratin
Figure 4 : One year later, LGFMS recurred at the same location.
Surgical excision was performed with a 1-cm skin margin, and
a skin graft was applied.
Figure 5 : Fifteen months later, re-excision was made with a 2-
cm skin margin, and reconstruction with a local skin flap and a
skin graft was performed.
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sarcoma are strongly positive for vimentin antibody,
but are generally negative for α -smooth muscle ac-
tin, desmin, S-100 protein, cytokeratin, CD34, and
CD56 antibodies. In addition to these features,
Zámecník and Michal described the presence of
strong and diffuse bcl-2 reactivity (5), although we
did not investigate bcl-2 reactivity in the present pa-
tient.
The differential diagnosis of LGFMS in terms of
other malignant tumors chiefly includes malignant
fibrous histiocytoma and myxofibrosarcoma. Typi-
cal malignant fibrous histiocytoma is considerably
more cellular and has greater malignant potential
than LGFMS, that is, it shows greater nuclear hy-
perchromatism, pleomorphism, and mitotic activity.
Myxofibrosarcomas are classified into 4 grades,
with grade 1 myxofibrosarcoma considered to re-
semble LGFMS. However, this tumor can be dif-
ferentiated from LGFMS by the greater degree of
nuclear atypia, predominant myxoid component,
and absence of metastasis ; further myxofibrosar-
coma generally occurs in older adults. Moreover,
a t(7 ; 16)(q34 ; p11) translocation resulting in a
FUS/CREB3L2 fusion transcript has been reported
in more than 95% of LGFMS cases when combina-
tions of classic cytogenetic and molecular cytoge-
netic methods, such as reverse transcription polym-
erase chain reaction (RT-PCR) and fluorescence
in situ hybridization (FISH), are employed. A rare
FUS/CREB3L1 variant has also recently been de-
scribed in a small subset of LGFMS cases (6). Al-
though we did not attempt to analyze these fusion
genes, these methods may be valuable tools in the
differential diagnosis (7).
Undoubtedly, adequate surgical excision of the tu-
mor is necessary, because of the frequent recur-
rence of LGFMS. Although a vertical incision that
includes barriers such as the thick fascia or pe-
riosteum is recommended, as based on the criteria
for soft malignant tumors, potential advantages of
a horizontal skin incision remain to be elucidated.
In our patient, a 1-cm skin margin was not sufficient
and therefore, during the second operation, an ex-
tended 2-cm skin margin was employed. At 1 year
after the second surgery, there is no obvious evi-
dence of recurrence ; nonetheless, a long follow-
up period is important. Adjuvant radiotherapy or
chemotherapy has not been recommended in pre-
vious reports ; however, these treatment strategies
may be used in cases of multiple metastases or fre-
quent recurrence.
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